Leonie Apperloo
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Neonatal Respiratory Health Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Cystic Fibrosis Research Advances
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 2
-
- Sirtuins and Resveratrol in Medicine 1
- Co-authors
- Djoke van Gosliga (3 shared papers)Maarten van den Berge (3 shared papers)Martijn C. Nawijn (3 shared papers)Heidi H. van der Ende-Metselaar (2 shared papers)Berit Troost (2 shared papers)Jolanda M. Smit (2 shared papers)Denise P.I. van de Pol (2 shared papers)Izabela A. Rodenhuis‐Zybert (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (1 paper)Nature (1 paper)Viruses (1 paper)Nature Medicine (1 paper)Thorax (1 paper)
- Partner nations
- NetherlandsFranceUnited Kingdom
In The Last Decade
Leonie Apperloo
5 papers receiving 560 citations
Leonie Apperloo's Hit Papers
Peers
Comparison fields: 5 of 68
- Pulmonary and Respiratory Medicine 157
- Infectious Diseases 67
- Molecular Biology 222
- Drug Discovery 1
- Geriatrics and Gerontology 8
Countries citing papers authored by Leonie Apperloo
This map shows the geographic impact of Leonie Apperloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonie Apperloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonie Apperloo more than expected).
Fields of papers citing papers by Leonie Apperloo
This network shows the impact of papers produced by Leonie Apperloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonie Apperloo. The network helps show where Leonie Apperloo may publish in the future.
Co-authors
The 18 scholars most cited alongside Leonie Apperloo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | An integrated cell atlas of the lung in health and disease Hit paper breakdown → | 2023 | 471 |
| 2 | 2021 | 66 | |
| 3 | 2021 | 20 | |
| 4 | 2024 | 6 | |
| 5 | 2026 | 2 |
About Leonie Apperloo
Leonie Apperloo is a scholar working on Infectious Diseases, Geriatrics and Gerontology, Physiology, Molecular Biology and Epidemiology, having authored 5 papers that have together received 565 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), Virology and Viral Diseases (1 paper), RNA Research and Splicing (1 paper), Single-cell and spatial transcriptomics (1 paper), Sirtuins and Resveratrol in Medicine (1 paper), Asthma and respiratory diseases (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (157 citations), Infectious Diseases (67 citations), Molecular Biology (222 citations), Drug Discovery (1 citation) and Geriatrics and Gerontology (8 citations). Leonie Apperloo has collaborated with scholars based in Netherlands, France and United Kingdom. Frequent co-authors include Djoke van Gosliga, Maarten van den Berge, Martijn C. Nawijn, Heidi H. van der Ende-Metselaar, Berit Troost, Jolanda M. Smit, Denise P.I. van de Pol, Izabela A. Rodenhuis‐Zybert, Peter H. J. van der Voort and Jill Moser. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Nature, Viruses, Nature Medicine and Thorax.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.